"Antigen Presentation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The process by which antigen is presented to lymphocytes in a form they can recognize. This is performed by antigen presenting cells (APCs). Some antigens require processing before they can be recognized. Antigen processing consists of ingestion and partial digestion of the antigen by the APC, followed by presentation of fragments on the cell surface. (From Rosen et al., Dictionary of Immunology, 1989)
| Descriptor ID |
D017951
|
| MeSH Number(s) |
G12.119 G12.450.050.400.070
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Antigen Presentation".
Below are MeSH descriptors whose meaning is more specific than "Antigen Presentation".
This graph shows the total number of publications written about "Antigen Presentation" by people in this website by year, and whether "Antigen Presentation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 3 | 1 | 4 |
| 1995 | 1 | 2 | 3 |
| 1996 | 2 | 0 | 2 |
| 1997 | 4 | 0 | 4 |
| 1998 | 4 | 3 | 7 |
| 1999 | 5 | 4 | 9 |
| 2000 | 0 | 3 | 3 |
| 2001 | 6 | 6 | 12 |
| 2002 | 5 | 4 | 9 |
| 2003 | 7 | 4 | 11 |
| 2004 | 0 | 5 | 5 |
| 2005 | 1 | 2 | 3 |
| 2006 | 1 | 6 | 7 |
| 2007 | 0 | 7 | 7 |
| 2008 | 2 | 6 | 8 |
| 2009 | 3 | 5 | 8 |
| 2010 | 3 | 3 | 6 |
| 2011 | 0 | 1 | 1 |
| 2012 | 5 | 5 | 10 |
| 2013 | 5 | 10 | 15 |
| 2014 | 3 | 5 | 8 |
| 2015 | 0 | 5 | 5 |
| 2016 | 4 | 2 | 6 |
| 2017 | 0 | 4 | 4 |
| 2018 | 1 | 0 | 1 |
| 2019 | 1 | 2 | 3 |
| 2020 | 1 | 6 | 7 |
| 2021 | 2 | 4 | 6 |
| 2022 | 1 | 2 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antigen Presentation" by people in Profiles.
-
Deaza-modification of MR1 ligands modulates recognition by MR1-restricted T cells. Sci Rep. 2022 12 29; 12(1):22539.
-
Isolating and targeting a highly active, stochastic dendritic cell subpopulation for improved immune responses. Cell Rep. 2022 11 01; 41(5):111563.
-
Positive and negative selection shape the human naive B cell repertoire. J Clin Invest. 2022 01 18; 132(2).
-
Mouse Homologue of Human HLA-DO Does Not Preempt Autoimmunity but Controls Murine Gammaherpesvirus MHV68. J Immunol. 2021 12 15; 207(12):2944-2951.
-
Reprogramming of Neutrophils as Non-canonical Antigen Presenting Cells by Radiotherapy-Radiodynamic Therapy to Facilitate Immune-Mediated Tumor Regression. ACS Nano. 2021 Nov 23; 15(11):17515-17527.
-
MHC Class II Antigen Presentation by Lymphatic Endothelial Cells in Tumors Promotes Intratumoral Regulatory T cell-Suppressive Functions. Cancer Immunol Res. 2021 07; 9(7):748-764.
-
Site-specific antigen-adjuvant conjugation using cell-free protein synthesis enhances antigen presentation and CD8+ T-cell response. Sci Rep. 2021 03 18; 11(1):6267.
-
Soluble N-Acetylgalactosamine-Modified Antigens Enhance Hepatocyte-Dependent Antigen Cross-Presentation and Result in Antigen-Specific CD8+ T Cell Tolerance Development. Front Immunol. 2021; 12:555095.
-
Persistent antigen exposure via the eryptotic pathway drives terminal T cell dysfunction. Sci Immunol. 2021 02 26; 6(56).
-
Integrated digital pathology and transcriptome analysis identifies molecular mediators of T-cell exclusion in ovarian cancer. Nat Commun. 2020 11 04; 11(1):5583.